gerontology

Clinical stage biopharma company resTORbio, Inc. (NASDAQ: TORC)'s TORC1 inhibition program uses a protein called serine/threonine kinase that aims to regulate aging and aging-related diseases conditions without undesirable side effects. The Analyst Wedbush analyst Robert Driscoll...